prov:value
| - methylamine; diabetes, fasting plasma glucose (IFG), metabolic acidosis, ketosis, appetite regulation, obesity, immunosuppressants or cytokine release regulation, autoimmune diseases such as inflammatory bowel disease, multiple sclerosis and arthritisUS7723344Aug 12, 2004May 25, 2010Takeda San Diego, Inc.Dipeptidyl peptidase inhibitorsUS7732446Mar 9, 2005Jun 8, 2010Takeda Pharmaceutical Company Li
|